Vaxart Market Cap

Vaxart has a market cap or net worth of $131.37 million as of April 19, 2024. Its market cap has increased by 62.79% in one year.

Market Cap

131.37M

Enterprise Value

111.75M

1-Year Change

62.79%

Ranking

#3846

Market Cap Chart

Since December 1, 1998, Vaxart's market cap has increased from $89.40M to $131.37M, an increase of 46.95%. That is a compound annual growth rate of 1.53%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	146.40M	-2.79%
Apr 17, 2024	150.60M	-3.09%
Apr 16, 2024	155.40M	-1.65%
Apr 15, 2024	158.00M	-0.13%
Apr 12, 2024	158.20M	-12.50%
Apr 11, 2024	180.80M	2.96%
Apr 10, 2024	175.60M	-2.88%
Apr 9, 2024	180.80M	-3.73%
Apr 8, 2024	187.80M	-
Apr 5, 2024	187.80M	-4.43%
Apr 4, 2024	196.50M	-8.09%
Apr 3, 2024	213.80M	-0.83%
Apr 2, 2024	215.60M	-4.60%
Apr 1, 2024	226.00M	-
Mar 28, 2024	226.00M	0.76%
Mar 27, 2024	224.30M	5.75%
Mar 26, 2024	212.10M	-0.80%
Mar 25, 2024	213.80M	-2.42%
Mar 22, 2024	219.10M	2.48%
Mar 21, 2024	213.80M	-0.83%
Mar 20, 2024	215.60M	6.89%
Mar 19, 2024	201.70M	-
Mar 18, 2024	201.70M	7.40%
Mar 15, 2024	187.80M	-1.78%
Mar 14, 2024	191.20M	11.29%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cybin	154.23M
ProQR Therapeutics	153.55M
Regulus Therapeutics	153.19M
Quipt Home Medical	151.99M
INmune Bio	151.96M
I-Mab	150.21M
ClearPoint Neuro	149.18M
American Well	148.65M

Market Cap Rankings